To Ocugen CEO Shankar Musunuri, Ph.D., most gene therapy biotechs today lack vision. | Many gene therapy outfits focus on ...
Telix Pharmaceuticals Ltd (ASX:TLX) has delivered a sharp reminder of how quickly sentiment can swing in biotech — with a ...
New research from researchers at the University of Florida, University of Maryland and Yale School of Public Health has found that if measles, mumps and rubella (MMR) immunization rates continue to ...
In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...
Pulte Home Co. wants to build as many as 99 homes on 60 acres near Interstate 95 and Indiantown Road, one of the last large ...
New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.
Explore the evolving healthcare theme in the Rekha Rakesh Jhunjhunwala portfolio as of March 2026. This deep dive analyzes ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
Global CPHI events underscore international sourcing and partnership dynamics, with Shanghai’s CPHI & PMEC China illustrating ...
Collaboration with leading European orthopedic center in Italy supports GelrinC® clinical adoptionRenowned cartilage ...
The managers have proven that they can protect investors against downturns while growing savings over the long term ...
US startup Bond Pet Foods has welcomed Germany's Symrise as an investor, with the firms partnering to create new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results